Intramedullary Spinal Cord Metastasis From Endometrial Cancer Eight Years After the Initial Diagnosis: A Case Report

Intramedullary spinal cord metastasis (ISCM) is a rare manifestation of central nervous system metastasis, and ISCM originating from endometrial cancer is extremely uncommon. Here, we report a case of ISCM from endometrial cancer that developed eight years after the initial diagnosis. An 82-year-old woman presented with bilateral hand weakness and posterior neck pain. She had a history of endometrial cancer (endometrioid carcinoma with highly atypical/serous-like components, pT4N1M1, Stage IVB) treated with surgery and adjuvant chemotherapy eight years prior. Her clinical course included a mediastinal recurrence, which was surgically resected and definitively confirmed as Müllerian in origin (PAX-8 positive) despite focal TTF-1 positivity, and multiple brain metastases treated with stereotactic radiosurgery. Magnetic resonance imaging (MRI) revealed an intramedullary enhancing mass at the C6-C7 level with extensive edema. CA125 levels were remarkably elevated (263.5 U/ml), correlating with disease activity. Based on the clinical course, typical MRI findings, and biomarker trends, she was clinically diagnosed with ISCM from endometrial cancer. Palliative radiotherapy (30 Gy in 10 fractions) was administered, resulting in significant pain relief (Numerical Rating Scale score improved from 5-6 to 0-1) and a slight improvement in muscle strength. The patient eventually transitioned to hospice care and passed away due to disease progression. Although ISCM from endometrial cancer is exceptionally rare, its incidence may increase owing to the prolonged survival of cancer patients. Palliative radiotherapy is a valuable and viable option for symptom management in these patients.

Authors

Publication Details

Journal
Cureus
Published
2026-11-19
DOI
https://doi.org/10.7759/cureus.119929
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Intramedullary Spinal Cord Metastasis From Endometrial Cancer Eight Years After the Initial Diagnosis: A Case Report

Takuya Kawamura, Yui Nanpei, Shuji Kodama, Mikiko Sakai et al.
Cureus
Management of metastatic bone disease
article

Intramedullary Spinal Cord Metastasis From Endometrial Cancer Eight Years After the Initial Diagnosis: A Case Report

Takuya Kawamura, Yui Nanpei, Shuji Kodama, Mikiko Sakai, Masamichi Yoshida
article en

Abstract

Intramedullary spinal cord metastasis (ISCM) is a rare manifestation of central nervous system metastasis, and ISCM originating from endometrial cancer is extremely uncommon. Here, we report a case of ISCM from endometrial cancer that developed eight years after the initial diagnosis. An 82-year-old woman presented with bilateral hand weakness and posterior neck pain. She had a history of endometrial cancer (endometrioid carcinoma with highly atypical/serous-like components, pT4N1M1, Stage IVB) treated with surgery and adjuvant chemotherapy eight years prior. Her clinical course included a mediastinal recurrence, which was surgically resected and definitively confirmed as Müllerian in origin (PAX-8 positive) despite focal TTF-1 positivity, and multiple brain metastases treated with stereotactic radiosurgery. Magnetic resonance imaging (MRI) revealed an intramedullary enhancing mass at the C6-C7 level with extensive edema. CA125 levels were remarkably elevated (263.5 U/ml), correlating with disease activity. Based on the clinical course, typical MRI findings, and biomarker trends, she was clinically diagnosed with ISCM from endometrial cancer. Palliative radiotherapy (30 Gy in 10 fractions) was administered, resulting in significant pain relief (Numerical Rating Scale score improved from 5-6 to 0-1) and a slight improvement in muscle strength. The patient eventually transitioned to hospice care and passed away due to disease progression. Although ISCM from endometrial cancer is exceptionally rare, its incidence may increase owing to the prolonged survival of cancer patients. Palliative radiotherapy is a valuable and viable option for symptom management in these patients.

Cureus
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon